Work

Sphingosine Kinase 1 – A Therapeutic Opportunity for Alleviating Liver Fibrosis?

Year: 2024
Type: editorial
Abstract: Liver fibrosis (LF) is a clinical manifestation of underlying liver disease and metabolic disorders, where functional liver tissue is replaced by non-functional collagen fibers arising from the extracellular matrix. It is an escalating concern, as the incidence of LF is surging due to rising prevalence of alcoholic liver disease and metabolic dysfunction-associated steatotic liver disease.1,2 LF is reversible; however, many patients suffer from this condition unnoted, until it deteriorates into liver cirrhosis and liver cancer.
Language: English
Open Access status: gold
Estimated APC paid: $3,030
OpenAlex ID: W4404963958
Cites: 10
Cited by:
Related to: 10